NCT07446465 2026-03-03
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
Fudan University
Phase 4 Not yet recruiting
Fudan University
Gruppo Oncologico del Nord-Ovest
University of Chicago
Xijing Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Tongji Hospital
China Meitan General Hospital
Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
Hebei Medical University
Fudan University
Hebei Medical University
Nanjing Medical University